Best Life Sciences Platforms and Tools Companies in Arizona, United States

Biosensing Instrument is a precision scientific instruments company focused on developing molecular analytical instruments based on Surface Plasmon Resonance technology. The company's proprietary Bi-DirectFlow SPR technology allows combining precise sample delivery at small volume with a noise and drift cancellation technique to meet the requirements for a diverse set of applications in life science, electrochemistry, chemical vapor research, and environmental safety.

Funding rounds

• Apr 2025Grant (prize money)$349.6K
• Sep 2024Grant (prize money)$295.6K
• Aug 2021Grant (prize money)$2.2M
• May 2021Grant (prize money)$1.7M

Founders & team

Tianwei JingPresident and Co-founder

Investors

HHS

Tech stack

Animate.CssBootstrapCloudflareCloudflare Bot ManagementCore-JsFamethemes Onepress

Luceome Biotechnologies is a drug discovery company focused on developing its assay technology for the identification of drugs against kinases. It provides unique assay solutions (KinaseSeeker and KinaseLite) which are based on a technology platform that utilizes luciferase fragment complementation and the resulting luminescence allows the identification of the target and off-target effects of drug candidates.

Provider of fertility management solutions for pest control. The company's first product applies the technology to the problem of the proliferation of rats in both urban and agricultural settings. The compound is readily consumed by rats and leaves them non-reproductive with no other observable side effects. The rodents live out their normal 8-12 month life span without producing offspring.

Integrated biomechanics, imaging, and electrophysiology tools for in vitro research. The company provides innovative solutions for replicating in vivo cellular environments in controlled in vitro settings. They offer all-in-one systems and stand-alone modules for electrophysiology, mechanics, and imaging, including flexible and stretchable multi-electrode arrays (MEAs), glass MEAs, 3D-MEAs, and microfluidics. Their products support applications like neuroprotective drug screening, alternatives to animal testing, cell culture, and cardiac action potentials. The company aims to improve the predictive accuracy of pre-clinical research by combining biomechanics and electrophysiology in a dynamic 3D environment, delivering more relevant and reliable data. They offer tools for cell stretching, imaging, and recording/stimulating electrophysiological activity, separately or concurrently. Their stretchable MEAs allow manipulation of chemical, electrical, and mechanical factors independently. The company focuses on providing accurate data, efficient workflows, and unrivaled results to better predict clinical outcomes and reduce failure rates in clinical trials.

Funding rounds

• Sep 2022Grant (prize money)$2.1M
• Sep 2021Grant (prize money)$474.6K
• Jan 2020Grant (prize money)$15K
• Oct 2018Grant (prize money)—

Founders & team

Oliver GraudejusFounder & CEO

Investors

Invest Southwest, MassChallenge, HHS

PathogenDX provides DNA-based pathogen testing kits. They offer Delivering Disruptive Testing Technology to the botanicals, food, and agriculture industries. The company focuses on food and agricultural microbial testing, cannabis testing, and botanical testing.

Funding rounds

• Aug 2020Grant (prize money)—
• Aug 2020Grant (prize money)$1.1M
• Sep 2019Series B$7.5M
• Jul 2018Series A$3.4M

Founders & team

Milan PatelCEO and Co-FounderMichael HoganCo-Founder & CSO

Investors

NIH, Salveo Capital, Altitude Investment Management, Canopy Ventures, Entourage Effect Capital, Arcadian Investment Partners

Tech stack

WordpressMysqlPhpGoogle MapsNginxWpbakery

Developer of microscopic-imaging instrumentation for telepathology and life science applications. The company's patented imaging technology accelerates microscopy image-data acquisition. The instrumentation integrates optical design, digital imaging, telecommunications, and bioinformatics. The company's expertise includes optics, electronics, instrumentation, digital image analysis, and pathology. The technology has applications in digital pathology and life sciences.

Funding rounds

• Jul 2013Grant (prize money)$335.5K
• Sep 2010Grant (prize money)$6.7M
• Aug 2010Grant (prize money)$3.3M

Founders & team

Artur OlszakFounder & CEO

Investors

HHS

Early cancer detection through advanced nano-biotechnology and genome sequencing. The company focuses on developing innovative nano-biotechnology platforms and machine learning tools for high-accuracy, early-stage disease diagnostics. They aim to extract systems-scale information from complex disease biology to identify and detect disease-specific molecular biomarkers at pre-symptomatic stages. Their technology includes exponential nanosensors (FDEC) and advanced 3D nanopore-transistor devices for rapid, low-cost genome sequencing. This enables early cancer detection through simple blood tests, potentially eliminating the need for biopsies. The goal is to enable preemptive medicine by facilitating early personalized therapeutic intervention, ultimately improving patient outcomes and reducing healthcare costs. This is a B2B tech company.

Developer of miniaturized research and diagnostic tools using microfluidic technology. These tools enable precise fluid handling at extremely small scales, facilitating advancements in disease detection and treatment. The technology is applied to various applications, including high-throughput biomarker screening and cryo-EM sample preparation. Commercialization partnerships are in place to expand market reach.

Funding rounds

• Jun 2012Grant (prize money)$149.8K
• May 2012Grant (prize money)$149.8K
• Sep 2010Grant (prize money)$2.2M
• Sep 2010Grant (prize money)$427.2K

Founders & team

Peter KahnCEO & Managing Director

Investors

HHS

Real-time microbial monitoring systems for liquid contaminant detection and quantification. The company provides advanced monitoring solutions for detecting and quantifying microbial and inert particle contaminants in liquids. Their systems cater to online continuous monitoring of purified water, ultra-pure water, and water for injection systems. They offer solutions for critical control points, process control, optimization, and point-of-use monitoring. These systems are applicable in aseptic manufacturing areas, in-process and production areas, cleaning validation, and product monitoring. This technology enables real-time insights, enhancing quality control and process efficiency across various industries. This is a B2B business model.

Sentinel Monitoring Systems develops online tools to monitor the bioburden during manufacturing. Its products include Sentinel Online Monitor, which is a multivariate spectroscopic analyzer for real-time monitoring of bioburden and other target analytes, and Sentinel Sample Collector, which automatically captures excursion or periodic samples as required, and a Fountain Flow Cytometry (FFC) which quantifies bioburden.

Pinnacle Transplant Technologies is a developer of regenerative products. The company is a multi-service tissue bank that develops allograft tissues for medical professionals. The products developed are sponge cube, sponge strip, DBM Fiber and DBM Putty.

Funding rounds

• Apr 2015Series A$2.5M

Founders & team

Noah StromerFounderRoger RosePresident and Chief Executive Officer

Investors

Center for Entrepreneurial Innovation

Tech stack

AhrefsApache Http ServerDocusignElementorGodaddyGoogle Cloud

Provider of technology for gene expression analysis of tumor samples. It's platform technology LightStream FloCell uses microfluidics and advanced analytic algorithms to create in situ expression profiles for tumor samples called the Tumor Heterogeneity Profile (THP). The THP enables researchers to study gene expression profiles in the context of intact tissue morphology.